Kuang Z, Kong M, Yan N, Ma X, Wu M, Li J
Curr Treat Options Oncol. 2024; 25(5):679-701.
PMID: 38676836
PMC: 11082000.
DOI: 10.1007/s11864-024-01203-6.
Hernandez-Gonzalez V, Conesa-Milian E, Jove-Deltell C, Pano-Rodriguez A, Legaz-Arrese A, Reverter-Masia J
Front Pediatr. 2024; 12:1285794.
PMID: 38374876
PMC: 10875851.
DOI: 10.3389/fped.2024.1285794.
Conesa-Milian E, Cirer-Sastre R, Hernandez-Gonzalez V, Legaz-Arrese A, Corbi F, Reverter-Masia J
Healthcare (Basel). 2023; 11(16).
PMID: 37628539
PMC: 10454241.
DOI: 10.3390/healthcare11162342.
Nyarko O, Sucharov C
J Cardiovasc Aging. 2023; 3(3).
PMID: 37484982
PMC: 10361342.
DOI: 10.20517/jca.2023.15.
Diggelmann A, Baron Toaldo M, Bektas R, Furthner E, Reichler I, Kutter A
Animals (Basel). 2023; 13(12).
PMID: 37370419
PMC: 10295038.
DOI: 10.3390/ani13121909.
Central laboratory and point-of-care cardiac marker testing capacity of tertiary hospitals in Nigeria - a multicenter study.
Meka I, Otokunefor O, Ene A, Ojo O, Manu M, Okwara E
Afr Health Sci. 2022; 22(2):247-256.
PMID: 36407390
PMC: 9652624.
DOI: 10.4314/ahs.v22i2.28.
Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications.
Heuts S, Gollmann-Tepekoylu C, Denessen E, Olsthoorn J, Romeo J, Maessen J
Eur Heart J. 2022; 44(2):100-112.
PMID: 36337034
PMC: 9897191.
DOI: 10.1093/eurheartj/ehac604.
Value of troponin T as a screening test of cardiac structure and function in chronic kidney disease.
Nasr F, Metwaly A, Abdel Khalik A, Raafat M, Nabil M, Kamel L
Glob Cardiol Sci Pract. 2022; 2021(4):e202126.
PMID: 36185160
PMC: 9491400.
DOI: 10.21542/gcsp.2021.26.
Value of troponin T measurements for prediction of postoperative course and length of ICU stay of children after surgical correction of congenital heart disease.
Boronski B, Piotrowski A, Pagowska-Klimek I
Anaesthesiol Intensive Ther. 2022; 54(2):114-119.
PMID: 35413784
PMC: 10156510.
DOI: 10.5114/ait.2022.114488.
Kinetics, Moderators and Reference Limits of Exercise-Induced Elevation of Cardiac Troponin T in Athletes: A Systematic Review and Meta-Analysis.
Li F, Hopkins W, Wang X, Baker J, Nie J, Qiu J
Front Physiol. 2021; 12:651851.
PMID: 33841187
PMC: 8033011.
DOI: 10.3389/fphys.2021.651851.
Effects of medium- and long-distance running on cardiac damage markers in amateur runners: a systematic review, meta-analysis, and metaregression.
Rubio-Arias J, Andreu L, Martinez-Aranda L, Martinez-Rodriguez A, Manonelles P, Ramos-Campo D
J Sport Health Sci. 2021; 10(2):192-200.
PMID: 33742602
PMC: 7987568.
DOI: 10.1016/j.jshs.2019.10.003.
T-wave heterogeneity in standard resting 12-lead ECGs is associated with 90-day cardiac mortality in women following emergency department admission: A nested case-control study.
Monteiro F, Rabelo Evangelista A, Nearing B, Medeiros S, Tessarolo Silva F, Pedreira G
Ann Noninvasive Electrocardiol. 2021; 26(3):e12826.
PMID: 33543816
PMC: 8164148.
DOI: 10.1111/anec.12826.
Circulating and tissue biomarkers as predictors of bromine gas inhalation.
Masjoan Juncos J, Shakil S, Ahmad A, Aishah D, Morgan C, DellItalia L
Ann N Y Acad Sci. 2020; 1480(1):104-115.
PMID: 32645215
PMC: 7708511.
DOI: 10.1111/nyas.14422.
Exercise-induced release of troponin.
Stavroulakis G, George K
Clin Cardiol. 2020; 43(8):872-881.
PMID: 31975465
PMC: 7403670.
DOI: 10.1002/clc.23337.
Cardiac troponins: from myocardial infarction to chronic disease.
Park K, Gaze D, Collinson P, Marber M
Cardiovasc Res. 2017; 113(14):1708-1718.
PMID: 29016754
PMC: 5852618.
DOI: 10.1093/cvr/cvx183.
microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment.
Koturbash I, Tolleson W, Guo L, Yu D, Chen S, Hong H
Biomark Med. 2015; 9(11):1153-76.
PMID: 26501795
PMC: 5712454.
DOI: 10.2217/bmm.15.89.
Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care.
Farthing D, Farthing C, Xi L
Exp Biol Med (Maywood). 2015; 240(6):821-31.
PMID: 25956679
PMC: 4935215.
DOI: 10.1177/1535370215584931.
Chapter 5: Referral to specialists and models of care.
Kidney Int Suppl (2011). 2015; 3(1):112-119.
PMID: 25599001
PMC: 4284442.
DOI: 10.1038/kisup.2012.68.
Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD.
Kidney Int Suppl (2011). 2015; 3(1):91-111.
PMID: 25599000
PMC: 4284425.
DOI: 10.1038/kisup.2012.67.
Normalization of elevated cardiac, kidney, and hemolysis plasma markers within 48 h in Mexican Tarahumara runners following a 78 km race at moderate altitude.
Christensen D, Espino D, Infante-Ramirez R, Brage S, Terzic D, Goetze J
Am J Hum Biol. 2014; 26(6):836-43.
PMID: 25145663
PMC: 4237147.
DOI: 10.1002/ajhb.22607.